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 Executive Summary
Survey of digestive health across Europe:
Final report
Introduction
United European Gastroenterology (UEG) which represents gastroenterology and hepatology and its sub-disci-
plines across Europe relies on accurate and up to date information on the burden of gastrointestinal diseases in
Europe, the availability and quality of diagnostic and therapeutic services and the economic impact of these
diseases across the member countries of the European Union to inform its strategy in advising relevant agencies
on future clinical services and research priorities. Determining the trajectory of the morbidity and mortality of
digestive diseases is vital in planning health services for the future and in making the case for investment in
research where there are clear gaps in knowledge. In addition there are marked economic diﬀerences across the
member nations in Europe and this is reﬂected in the funding available to support health services, making it highly
likely that there are important disparities in the accessibility to high-quality healthcare.
In September 2012 the UEG Council accepted a proposal from the UEG Future Trends Committee to com-
mission a detailed survey of digestive health across Europe. The Future Trends Committee developed an outline
framework for the study, following which there was an open, competitive process across Europe to identify a
competent research group to undertake the project. The contract was awarded to an experienced group within the
College of Medicine, Swansea University, United Kingdom, and the project was formally initiated in April 2013.
The research group at Swansea has worked closely with the Committee, including an interim update meeting
with the Committee in October 2013. The Committee also had the opportunity to make speciﬁc comments on a
draft ﬁnal report submitted in May 2014; a ﬁnal report, Survey of Digestive Health Across Europe was received in
August 2014. The ﬁnal report is organised into two parts: Part 1, The burden of gastrointestinal diseases and the
organisation and delivery of gastroenterology services across Europe and Part 2, The economic impact and burden of
digestive disorders. We present here the executive summaries of the two parts of the survey, but the full report can
be found on the UEG journal website. It is anticipated that several shorter publications will follow, focusing on
some speciﬁc topics of particular importance and interest.
Michael Farthing
President
United European Gastroenterology
Executive summary: Part 1: The burden of
gastrointestinal diseases and the organisation
and delivery of gastroenterology services
across Europe
Stephen E Roberts, David G Samuel, John G Williams,
Kymberley Thorne, Sian Morrison-Rees, Ann John,
Ashley Akbari and Judy C Williams
College of Medicine, Swansea University, UK
Purpose of the report
This report has been commissioned by the
United European Gastroenterology department.
Gastroenterology is a speciality that tends to receive
relatively little attention from a policy perspective
and, compared with other specialities, attracts rela-
tively little charitable research funding. One of
the remits of United European Gastroenterology is
to raise the political and public awareness of gastro-
intestinal disorders throughout Europe. To facilitate
this, this report is intended to draw together the
evidence and provide up to date information on the
public health burden of gastrointestinal disorders,
their human consequences, their economic burden
and the organisation and delivery of gastroenterology
services across Europe, including disease screening
programmes.
This report does not seek to replicate existing guid-
ance, which has been published for many gastrointes-
tinal diseases, but draws on evidence contained in some
of these documents. The ﬁrst part of this report covers
the burden of gastrointestinal diseases and the
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organisation and delivery of gastroenterology services
across Europe and the second addresses the economic
burden of gastrointestinal diseases, including patient
health related quality of life. The report is intended to
be of value to patient groups, clinicians, politicians,
managers and civil servants, especially those respon-
sible for developing or delivering services to patients
with gastrointestinal disorders across Europe.
Methods
This review covers the 28 countries that are member
states of the EU, along with Norway, Switzerland,
Liechtenstein and Russia and is focused on the most
recent years since 2000, although for comparative pur-
poses, some sections of the review also cover the 1990s,
the 1980s and the 1970s. The review examines all major
gastrointestinal disorders including gastro-oesopha-
geal, intestinal, hepato-biliary and pancreatic diseases,
gastrointestinal malignancies and other gastrointestinal
disorders and related conditions. Systematic reviews of
the medical literature were undertaken, along with
searches of grey literature, reports, websites and other
data sources to assess the public health and economic
burden of gastrointestinal disorders and the organisa-
tion and delivery of services in gastroenterology.
Main findings
Burden of disease.
. Incidence and prevalence data across Europe are
compiled routinely only for gastrointestinal cancers
and certain communicable diseases, so that most of
the available evidence on the burden of gastrointes-
tinal disorders is based on a large variety of individ-
ual studies, often with patchy population coverage
and varying data quality. The evidence base for
assessing the prevalence and public health burden
of most (non-communicable) liver diseases is par-
ticularly weak. There is an absence or major lack
of evidence from eastern Europe on the incidence
or prevalence of many gastrointestinal disorders.
. There have been increases in the incidence of most
gastrointestinal disorders in Europe which have major
implications for future healthcare provision. These
include upper gastrointestinal bleeding, Barrett’s
oesophagus, oesophagitis, inﬂammatory bowel disease
(in most countries), coeliac disease, diverticular disease,
alcoholic liver disease, primarybiliary cirrhosis, primary
sclerosing cholangitis, gallstone disease, hepatitis B and
C infections (in some countries), acute and chronic pan-
creatitis, oesophageal, colorectal and pancreatic cancer.
. The incidence and prevalence of many gastrointestinal
disorders are highest among older people. With an
ageing European population, this will also lead to
future increases in disease burden across Europe.
. The incidence of paediatric disorders such as inﬂamma-
tory bowel disease, coeliac disease and eosinophilic
oesophagitis is also increasing in many European
countries.
. Although under-reported in many eastern European
countries, the incidence or prevalence of many gastro-
intestinal disorders is often increased in these countries
when compared with other regions of Europe. These
disorders include gastro-oesophageal reﬂux disease,
helicobacter pylori infection, acute pancreatitis and
oesophageal, gastric, pancreatic and gallbladder
cancer. Mortality from (non-malignancy) gastrointes-
tinal diseases overall is highest in eastern and north-
eastern Europe and lowest in parts of Scandinavia and
the Mediterranean islands.
. There are important social inequalities for many
gastrointestinal disorders, within countries as well as
across Europe, including upper gastrointestinal bleed-
ing, gastro-oesophageal reﬂux disease helicobacter
pylori, peptic ulcer, liver cirrhosis, hepatitis B and C,
acute pancreatitis, oesophageal and gastric cancer.
. Both Crohn’s disease and ulcerative colitis show
east: west as well as north:south gradients in inci-
dence with highest rates usually in northern or west-
ern regions of Europe.
. Inﬂammatory bowel disease, gastro-oesophageal reﬂux
disease and hepatitis C have a major impact on work
productivity, absenteeism and work experiences across
European countries. Inﬂammatory bowel disease and
hepatitis C have also been shown to have a major
impact on health-related quality of life across Europe.
Mortality.
. Gastrointestinal cancer is the leading cause of cancer
death in Europe. It is also the most common cancer
in men and the second most common in women after
breast cancer.
. One and ﬁve-year survival following diagnosis with
major gastrointestinal malignancies is usually high-
est in central and western European countries.
Survival appears to be worse in parts of eastern
Europe, although there is still a lack of data from
some eastern European countries.
. Population-based mortality for colorectal cancer has
been falling over several decades in almost all west-
ern, northern and central European countries. It is
continuing to increase in many eastern European
countries – particularly for men – and in some
parts of southern Europe.
. Projections for colorectal cancer mortality indicate
continuing reductions in mortality over the next ﬁve
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to 10 years in northern and western Europe, but for
mortality to then level oﬀ or increase in some coun-
tries over the subsequent 10 years. Projections for
eastern Europe are for an increase or static level of
mortality in the next ﬁve to 10 years, but then a
subsequent reduction. Gastric cancer mortality is
expected to continue falling throughout Europe –
but with levelling mortality or increases in the
longer term for parts of western Europe – while
oesophageal cancer mortality is also forecast to
fall, although with interim increases in some eastern
European countries.
Human resources.
. There is an absence of accurate, up-to-date work-
force data across Europe relating to the number of
gastroenterologists per country and per head of
population.
. There is an absence of evidence from European
countries on both the content and quality of post-
graduate and undergraduate education and training
in gastroenterology. The experience in specialist
areas of gastroenterology varies between countries
and does not always follow the European curriculum
of gastroenterology.
Service provision.
. Colorectal cancer screening programmes are now
well established in the majority of European coun-
tries but their impact on mortality has not yet been
established fully. Most countries are still within the
ﬁrst 10 years of their programmes so full analysis
will take several years. It is also unclear whether
the introduction of colorectal screening programmes
across Europe may disadvantage other patient
groups that require regular endoscopy services.
. Upper gastrointestinal bleeding is managed variably
across Europe with a lack of consensus on best prac-
tice. Diﬀering policies are in place regarding the use
of pharmacological agents as well as the timing of
endoscopy. Access to out of hours and weekend
endoscopy services varies across countries and cen-
tres, although patient outcomes often do not appear
to be aﬀected by this.
. Endoscopy services are not currently viewed as a
priority policy and service area across Europe des-
pite its expansion and this has uncertain implications
for meeting future service demand. Nurse endosco-
pists have become increasingly an important part of
medical workforces and a core curriculum has pro-
vided a benchmarking process to ensure quality
assurance in endoscopy services. The impact on
increased nursing numbers on doctor training
remains unclear.
. The role of the inﬂammatory bowel disease nurse is
increasingly important in managing patient treat-
ments and is considered as an essential part of the
inﬂammatory bowel disease team in many countries.
Multi-disciplinary clinics are ad hoc in most
European countries, and tend to occur only in the
larger hospitals.
. The impact of inﬂammatory bowel disease on paedi-
atric patients’ social and psychological development
is often overlooked. Transitional inﬂammatory
bowel disease services are crucial to eﬀective care
for young adults with inﬂammatory bowel disease,
but structured services are often only available in
larger or regional hospitals.
. European inﬂammatory bowel disease registries are
increasingly being used to monitor patient outcomes
and will form an important analytical tool in produ-
cing future clinical guidelines.
. Very little data currently exist reﬂecting individual
European country adherence to clinical guide-
lines, as well as patient outcomes relating to
management.
. Despite national and international guidelines for
Barrett’s oesophagus, there remains considerable
variability in compliance to guidelines with regards
screening intervals, biopsy protocols, reporting and
therapies. Changes in more recent guidelines could
have implications for screening intervals and there-
fore the demand on endoscopy services.
. Contention remains over the absolute beneﬁts of
Barrett’s oesophagus surveillance programmes.
. Screening is not cost-eﬀective and intervention for
high grade dysplasia is controversial. Endoscopic
resection or therapies have become the treatment
of choice for high grade dysplasia and early cancer
detection across Europe and have resulted in
reduced morbidity for patients.
. Alcohol concern is a major public health concern
with increasing rates of end stage liver disease in
many countries, which have led to public health
campaigns and policies aimed at addressing drinking
patterns. However, there is currently a lack of evi-
dence as to the services oﬀered to patients with alco-
hol-related diseases across Europe.
. The demand for liver transplantation is
increasing and many European countries are
attempting to address this need with changes in
public health and ministerial policies and law.
Several countries operate as networks to maximise
the use of potential organs, but individual countries
still operate diﬀerent allocation policies for liver
transplantation.
Roberts et al. 541
Economic burden.
. Major diﬃculties in identifying and measuring the
economic and health-related quality of life burden
of gastrointestinal disorders across Europe include
variations in measurement and reporting of eco-
nomic costs and diﬀerent approaches to ﬁnancing
and providing healthcare in diﬀerent countries.
. There is very little or no information available about
the economic impact of gastrointestinal disorders
from countries other than France, Germany, Italy,
the Netherlands, Norway, Spain, Sweden and the
UK.
. The cost of inﬂammatory bowel disease care has
increased signiﬁcantly over the past decade, mainly
through the increased use of biological therapies.
Mainland European treatment costs are higher
than in the UK with a more aggressive, top down
approach for larger numbers of patients with IBD.
Recommendations for further research.
. This report has collated much evidence about the
human, public health and economic burden of
gastrointestinal diseases and the provision of gastro-
enterology services across Europe. Hopefully it will
help to improve healthcare and reduce inequalities.
. There is a general need for further research into the
incidence, prognosis and public health burden of
many gastrointestinal disorders across Europe, and
a particular need for more studies from eastern
Europe, along with pan-European and multinational
studies.
. There is generally poor reporting of health-related
quality of life and economic data, and a lack of clar-
ity about economic cost data. Further initiatives are
required, either directly by funding or indirectly
through lobbying, to encourage research that will
ﬁll these gaps. This would also help economic evalu-
ations that will inform decision makers about the
merits of therapeutic interventions.
. With the increasing availability of electronic medical
records and research using electronic health data,
particularly in the UK, Scandinavia and Germany,
there should be coordinated eﬀorts to use data rec-
orded at the point of care to inform research into the
personal, public health and economic burden of GI
diseases across all European countries. There would
be considerable beneﬁts to such research if clinical
data collection across Europe could be standardised,
using a common terminology such as SNOMED-
CT, and common patient record structure such as
that recommended by the Academy of Medical
Royal Colleges in the UK.
. Research funding for more pan-European studies
that establish the economic and health-related qual-
ity of life consequences of digestive disorders should
aim to further cross country comparisons. Thus,
whenever possible, the data should be collected
and presented in a standardised way to enable
more informed synthesis. An uncoordinated
approach will continue the fragmented picture that
exists at present, and pan-European or multinational
studies using standardised methodology will be par-
ticularly valuable.
Specific areas for further research.
. There is a particular need to address the extremely
weak evidence base relating to the prevalence and
public health burden of most liver diseases, as well
as gallstones, diverticular disease and Barrett’s
oesophagus.
. There is a general lack of evidence from across
Europe regarding the provision of services for
patients with alcohol-related disease. In particular,
as minimal alcohol pricing levels are introduced
across Europe, research will be required to assess
the impact of these policies on alcohol-related hos-
pitalisations and mortality.
. Further work is required to determine whether the
Child-Turcotte Pugh (TCP) or the Model for End-
Stage Liver Disease (MELD) score is the optimal
tool for predicting the need for, and outcomes fol-
lowing liver transplantation.
. For both non-variceal and variceal upper gastro-
intestinal bleeding there is a need to analyse current
evidence, in particular to inform consensus guide-
lines, and to clarify the optimal timing for endoscopy
after hospitalisation.
. The impact of inﬂammatory bowel disease on the
social and psychological development of paediatric
patients is often overlooked and should be explored.
An absence of published work on the beneﬁts of
transitional clinics for inﬂammatory bowel disease
should be addressed by interested and specialist
European groups.
. Further research will be required to assess whether
recent changes in guidelines for Barrett’s oesophagus
will have any eﬀects on patient outcomes.
. Updating existing workforce data on the number of
gastroenterologists per country and per head of
population must be a priority in order to plan
future services and to identify areas of need both
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within individual countries and across European
regions. Further research is also required to model
workforce needs to ensure that endoscopy services
are maintained for groups such as inﬂammatory
bowel disease patients and high risk cancer surveil-
lance groups.
. There is a need to map diﬀerent national curricula
for postgraduate and undergraduate education and
training in gastroenterology with a European cur-
riculum, and also address the predicted future
needs of the European population.
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